June 17, 2024 USA
The Sugar Science: Ask the Expert
Diamyd Medical’s CEO Ulf Hannelius discusses Decoding the Future: Leveraging Biomarkers in Antigen-Specific Immunotherapy for Type 1 Diabetes.
The Sugar Science is an interactive digital platform founded to curate the scientific conversation among type 1 diabetes (T1D) researchers.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.